Status:
COMPLETED
Characteristics of Patients With Amyloidosis & Heart Failure Being Evaluated for a Heart Transplant
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to describe the characteristics of patients with amyloidosis and severe heart failure being evaluated for cardiac and stem cell transplantation.
Detailed Description
Systemic amyloidosis is a progressive disease leading to organ failure and death. Treatment has improved survival with stem-cell transplantation. Unfortunately, patients with amyloidosis and severe he...
Eligibility Criteria
Inclusion
- Patients with amyloidosis
- NYHA class III or IV heart failure
- Patients undergoing heart transplant evaluation
- Patients less than 18 years of age
Exclusion
- Patients who have unstable pulse and blood pressure
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
End Date :
March 1 2007
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00456040
Start Date
March 1 2007
End Date
March 1 2007
Last Update
April 4 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.